MUPIROCIN for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 103 adverse event reports in the FDA FAERS database where MUPIROCIN was used for Psoriasis.
Most Reported Side Effects for MUPIROCIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 1,036 | 30.0% | 3 | 227 |
| Product use in unapproved indication | 793 | 22.9% | 3 | 17 |
| Macular degeneration | 771 | 22.3% | 0 | 222 |
| Off label use | 451 | 13.0% | 3 | 208 |
| Pain | 277 | 8.0% | 1 | 202 |
| Product use issue | 257 | 7.4% | 1 | 9 |
| Therapeutic product effect incomplete | 256 | 7.4% | 0 | 205 |
| Nausea | 240 | 6.9% | 1 | 199 |
| Pyrexia | 230 | 6.7% | 1 | 218 |
| Malaise | 226 | 6.5% | 1 | 206 |
| Weight decreased | 225 | 6.5% | 0 | 213 |
| Erythema | 214 | 6.2% | 0 | 158 |
| Headache | 214 | 6.2% | 1 | 167 |
| Paraesthesia oral | 205 | 5.9% | 0 | 196 |
| Chronic sinusitis | 200 | 5.8% | 0 | 197 |
Other Indications for MUPIROCIN
Product used for unknown indication (1,204)
Wound (209)
Staphylococcal infection (170)
Preoperative care (75)
Postoperative care (67)
Infection (64)
Rash (64)
Rhinitis (54)
Infection prophylaxis (53)
Nasal discomfort (45)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)